Maximizing inhibition of the renin-angiotensin system with high doses of converting enzyme inhibitors or angiotensin receptor blockers

被引:9
作者
Berl, Tomas [1 ]
机构
[1] Univ Colorado Hlth Sci, Div Nephrol, Denver, CO 80262 USA
关键词
D O I
10.1093/ndt/gfn239
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
引用
收藏
页码:2443 / 2447
页数:5
相关论文
共 26 条
[1]   Optimal dose of losartan for renoprotection in diabetic nephropathy [J].
Andersen, S ;
Rossing, P ;
Juhl, TR ;
Deinum, J ;
Parving, HH .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (08) :1413-1418
[2]   Long-term renoprotective effects of standard versus high doses of telmisartan in hypertensive nondiabetic nephropathies [J].
Aranda, P ;
Segura, J ;
Ruilope, LM ;
Aranda, FJ ;
Frutos, MA ;
López, V ;
de Novales, EL .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (06) :1074-1079
[3]   Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy [J].
Atkins, RC ;
Briganti, EM ;
Lewis, JB ;
Hunsicker, LG ;
Braden, G ;
de Crespigny, PJC ;
DeFerrari, G ;
Drury, P ;
Locatelli, F ;
Wiegmann, TB ;
Lewis, EJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (02) :281-287
[4]   Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease [J].
Bianchi, S. ;
Bigazzi, R. ;
Campese, V. M. .
KIDNEY INTERNATIONAL, 2006, 70 (12) :2116-2123
[5]  
Bidani A, 2006, AM J NEPHROL, V26, P632
[6]  
BURGESS E, 2007, J AM SOC NEPHROL, V18, pA57
[7]   Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL [J].
de Zeeuw, D ;
Remuzzi, G ;
Parving, HH ;
Keane, WF ;
Zhang, ZX ;
Shahinfar, S ;
Snapinn, S ;
Cooper, MF ;
Mitch, WE ;
Brenner, BM .
KIDNEY INTERNATIONAL, 2004, 65 (06) :2309-2320
[8]   Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes [J].
Epstein, Murray ;
Williams, Gordon H. ;
Weinberger, Myron ;
Lewin, Andrew ;
Krause, Scott ;
Mukherjee, Robin ;
Patni, Rajiv ;
Beckerman, Bruce .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (05) :940-951
[9]   Angiotensin II receptor blockade - Is there truly a benefit of adding an ACE inhibitor? [J].
Forclaz, A ;
Maillard, M ;
Nussberger, J ;
Brunner, HR ;
Burnier, M .
HYPERTENSION, 2003, 41 (01) :31-36
[10]   Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus [J].
Hollenberg, Norman K. ;
Parving, Hans-Henrik ;
Viberti, Giancarlo ;
Remuzzi, Giuseppe ;
Ritter, Susan ;
Zelenkofske, Steven ;
Kandra, Albert ;
Daley, William L. ;
Rocha, Ricardo .
JOURNAL OF HYPERTENSION, 2007, 25 (09) :1921-1926